When tumor size reached about 50 mm3, we treated them with B13.14.1 TCR transduced human CD4 T cells, CD8 T cells and the mixture of CD4 T cells and CD8 T cells intravenously, and set intravenous injection of Mock-T (untransduced T cell) and PBS as control groups. This evidence concerns the gene CD8A and neoplasm.